Literature DB >> 1357191

The human immunodeficiency virus (HIV) gag gene product p18 is responsible for enhanced fusogenicity and host range tropism of the highly cytopathic HIV-1-NDK strain.

J de Mareuil1, B Brichacek, D Salaun, J C Chermann, I Hirsch.   

Abstract

Formation of large syncytia and rapid cell killing are characteristics of the Zairian human immunodeficiency virus type 1 isolate HIV-1-NDK, which is highly cytopathic for CD4+ lymphocytes in comparison with the HIV-1-LAV prototype. Chimeric viruses containing different combinations of HIV-1-NDK genetic determinants corresponding to the splice donor, the packaging signal, and the coding sequence of the p18gag protein together with the HIV-1-NDK EcoRI5278-XhoI8401 fragment were obtained by polymerase chain reaction-directed recombination. Phenotypic analysis of recombinant viruses indicated that 75 amino acids from the N-terminal part of HIV-1-NDK p18gag protein together with the HIV-1-NDK envelope glycoprotein are responsible for enhanced fusogenicity of HIV-1-NDK in CD4+ lymphocytes as well as for enhanced infectivity of HIV-1-NDK in some CD4- cells lines. The HIV-1-NDK splice donor/packaging sequence and the sequence encoding the gag protein p25 were not important for the variation observed in HIV-1 fusogenicity.

Entities:  

Keywords:  Biology; Diseases; Examinations And Diagnoses; Genetics; Hiv Infections; Laboratory Examinations And Diagnoses; Viral Diseases

Mesh:

Substances:

Year:  1992        PMID: 1357191      PMCID: PMC240181     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Productive infection of CD4+ cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies.

Authors:  F Rey; G Donker; I Hirsch; J C Chermann
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

2.  HIV1 cytopathogenicity-genetic difference between direct cytotoxic and fusogenic effect.

Authors:  I Hirsch; D Salaun; B Brichacek; J C Chermann
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

3.  Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro.

Authors:  S Delassus; R Cheynier; S Wain-Hobson
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain.

Authors:  W A O'Brien; Y Koyanagi; A Namazie; J Q Zhao; A Diagne; K Idler; J A Zack; I S Chen
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

5.  Comparative immunofluorescence of murine leukemia virus-derived membrane-associated antigens.

Authors:  M Satake; R B Luftig
Journal:  Virology       Date:  1983-01-30       Impact factor: 3.616

6.  p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells.

Authors:  N Sharova; A Bukrinskaya
Journal:  AIDS Res Hum Retroviruses       Date:  1991-03       Impact factor: 2.205

7.  HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals.

Authors:  A Achour; O Picard; D Zagury; P S Sarin; R C Gallo; P H Naylor; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

8.  Interaction of a noncytopathic human immunodeficiency virus type 1 (HIV-1) with target cells: efficient virus entry followed by delayed expression of its RNA and protein.

Authors:  X Y Ma; K Sakai; F Sinangil; E Golub; D J Volsky
Journal:  Virology       Date:  1990-05       Impact factor: 3.616

9.  Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection.

Authors:  J D Jiang; F N Chu; P H Naylor; J E Kirkley; J Mandeli; J I Wallace; P S Sarin; A L Goldstein; J F Holland; J G Bekesi
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

10.  The env gene variability is not directly related to the high cytopathogenicity of an HIV1 variant.

Authors:  B Spire; I Hirsch; C Neuveut; J Sire; J C Chermann
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

View more
  5 in total

1.  Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals.

Authors:  G Sanchez; X Xu; J C Chermann; I Hirsch
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.

Authors:  Mary Jane Potash; Wei Chao; Galina Bentsman; Nicolae Paris; Manisha Saini; Jadwiga Nitkiewicz; Paula Belem; Leroy Sharer; Andrew I Brooks; David J Volsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-23       Impact factor: 11.205

3.  Sequences responsible for the distinctive hemolytic potentials of Friend and Moloney murine leukemia viruses are dispersed but confined to the psi-gag-PR region.

Authors:  J Richardson; A Corbin; F Pozo; S Orsoni; M Sitbon
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

4.  Genetic complementation between replication-defective mutants of HIV-1 and SIVagm.

Authors:  T Miura; R Shibata; A Adachi; T Kuwata; J Chen; M Jin; E Ido; M Hayami
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission.

Authors:  R Narwa; P Roques; C Courpotin; F Parnet-Mathieu; F Boussin; A Roane; D Marce; G Lasfargues; D Dormont
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.